Reference is made to the stock exchange announcement published by Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) on 9 April 2026 regarding the grant of share options to primary insider and CEO Jørgen Mann.
The announcement did not include the mandatory notification form. The notification form is attached to this announcement.
This information is subject to disclosure requirements pursuant to Article 19 of Regulation EU 596/2014 (the EU Market Abuse Regulation) and Section 5-12 of the Norwegian Securities Trading Act.
http://publish.ne.cision.com//Release/ViewReleaseHtml/EAAA76F49E2A71D9E0C856B0705FC7D6
https://mb.cision.com/Main/19175/4332859/4029503.pdf
(c) 2026 Cision. All rights reserved., source Press Releases - English